Biodexa Pharmaceuticals (BDRX) Short Interest Ratio & Short Volume

Short interest is the volume of Biodexa Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 189,600 shares of BDRX short. Learn More on Biodexa Pharmaceuticals' current short interest.

Biodexa Pharmaceuticals saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 189,600 shares, an increase of 183.8% from the previous total of 66,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Biodexa Pharmaceuticals: Sunshine Biopharma, Inc. (7.32%), SciSparc Ltd. (21.38%), Comera Life Sciences Holdings, Inc. (2.38%), Evelo Biosciences, Inc. (2.11%), GRI Bio, Inc. (0.61%), Panbela Therapeutics, Inc. (2.36%), Aditxt, Inc. (10.83%), NeuBase Therapeutics, Inc. (0.81%), China SXT Pharmaceuticals, Inc. (11.61%), 180 Life Sciences Corp. (3.30%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling BDRX is an investing strategy that aims to generate trading profit from Biodexa Pharmaceuticals as its price is falling. BDRX shares are trading up $0.58 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Biodexa Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BDRX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BDRX, twice per month. The most recent reporting period available is April, 15 2024.